We are live on ! Find out more
HI

Human Investing Portfolio holdings

AUM $771M
1-Year Est. Return 18.84%
This Fund
S&P 500
This Quarter Est. Return
+2.33%
1 Year Est. Return
+18.84%
3 Year Est. Return
+51.96%
5 Year Est. Return
+53.41%
10 Year Est. Return
AUM
$274M
AUM Growth
+$6.31M
Cap. Flow
+$537K
Cap. Flow %
0.2%
Top 10 Hldgs %
43.24%
Holding
380
New
39
Increased
75
Reduced
108
Closed
23

Top Sells

Rank Stock Value
1
MNST icon
Monster Beverage
MNST
+$3.34M
2
OPLN
Openlane
OPLN
+$1.51M
3
XLNX
Xilinx Inc
XLNX
+$1.43M
4
MSFT icon
Microsoft
MSFT
+$1.34M
5
PGR icon
Progressive
PGR
+$1.14M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 10.8%
2 Healthcare 10.63%
3 Technology 9.17%
4 Financials 5.98%
5 Consumer Staples 5.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IVV icon
1
iShares Core S&P 500 ETF
IVV
$872B
$28.8M 10.51%
97,687
+3,283
+3% +$951K
IEFA icon
2
iShares Core MSCI EAFE ETF
IEFA
$190B
$27.5M 10.04%
448,077
+29,754
+7% +$1.82M
IJH icon
3
iShares Core S&P Mid-Cap ETF
IJH
$122B
$16M 5.83%
410,930
+21,650
+6% +$830K
VNQ icon
4
Vanguard Real Estate ETF
VNQ
$39.2B
$9.2M 3.36%
105,202
+3,366
+3% +$295K
IJR icon
5
iShares Core S&P Small-Cap ETF
IJR
$110B
$7.64M 2.79%
97,615
+6,392
+7% +$496K
BNDX icon
6
Vanguard Total International Bond ETF
BNDX
$81.9B
$7.48M 2.73%
130,600
+8,163
+7% +$459K
IEMG icon
7
iShares Core MSCI Emerging Markets ETF
IEMG
$151B
$7.01M 2.56%
136,360
-4,565
-3% -$233K
BSV icon
8
Vanguard Short-Term Bond ETF
BSV
$44.7B
$6.29M 2.3%
78,091
+5,317
+7% +$424K
BIV icon
9
Vanguard Intermediate-Term Bond ETF
BIV
$28.8B
$4.34M 1.58%
50,135
+3,097
+7% +$262K
ABBV icon
10
AbbVie
ABBV
$443B
$4.23M 1.54%
58,176
-462
-0.8% -$36.3K
ITOT icon
11
iShares Core S&P Total US Stock Market ETF
ITOT
$94.3B
$3.48M 1.27%
52,186
-2,551
-5% -$167K
BLV icon
12
Vanguard Long-Term Bond ETF
BLV
$5.71B
$3.36M 1.23%
34,623
+1,971
+6% +$183K
GILD icon
13
Gilead Sciences
GILD
$162B
$3.36M 1.23%
49,695
+1,225
+3% +$80.6K
LYB icon
14
LyondellBasell Industries
LYB
$20B
$3.29M 1.2%
38,161
-1,140
-3% -$97.3K
NVO
15
Novo Nordisk
NVO
$208B
$3.24M 1.18%
126,930
-5,964
-4% -$147K
MCD icon
16
McDonald's
MCD
$192B
$3.02M 1.1%
14,543
-607
-4% -$120K
AVGO icon
17
Broadcom
AVGO
$1.85T
$3.01M 1.1%
104,450
-5,930
-5% -$173K
TXN icon
18
Texas Instruments
TXN
$252B
$2.83M 1.03%
24,691
+7,399
+43% +$827K
HD icon
19
Home Depot
HD
$331B
$2.72M 0.99%
13,099
-786
-6% -$157K
SBUX icon
20
Starbucks
SBUX
$120B
$2.66M 0.97%
31,742
-7,426
-19% -$582K
TSN icon
21
Tyson Foods
TSN
$20.4B
$2.59M 0.94%
32,029
-1,824
-5% -$141K
JNJ icon
22
Johnson & Johnson
JNJ
$618B
$2.48M 0.9%
17,791
-146
-0.8% -$20.2K
INTC icon
23
Intel
INTC
$455B
$2.44M 0.89%
51,002
-1,360
-3% -$67.4K
CMS icon
24
CMS Energy
CMS
$22.6B
$2.43M 0.89%
41,885
-2,649
-6% -$149K
MCO icon
25
Moody's
MCO
$82.8B
$2.36M 0.86%
12,069
+5,483
+83% +$1.04M

Similar funds

Human Investing's Q2 2019 Portfolio in Review

As of Q2 2019, Human Investing held 380 positions worth $274M, up 2.4% from $268M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Human Investing's Q2 2019 filing shows 39 new, 75 increased, 108 reduced and 23 closed positions. Its largest new stake was Designer Brands: 83,217 shares worth $1.59M. The largest sale was Monster Beverage, an estimated $3.34M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 11% of assets, up from 9.6% a quarter earlier, followed by Healthcare and Technology.

  • Human Investing's largest Q2 2019 buy was Designer Brands: 83,217 shares worth $1.59M.
  • Human Investing added most to iShares Core MSCI EAFE ETF in Q2 2019, an estimated $1.82M increase.
  • Human Investing's biggest Q2 2019 reduction was Openlane, cutting an estimated $1.51M.
  • Human Investing fully exited Monster Beverage in Q2 2019, selling an estimated $3.34M.
  • Human Investing's ten largest holdings make up 43% of its $274M portfolio in Q2 2019.
  • Human Investing opened 39 new positions and closed 23 in Q2 2019.
  • Human Investing's portfolio value rose 2.4% quarter-over-quarter to $274M.

Based on Human Investing's 13F filing for Q2 2019, filed 16 Aug 2019.